Clinical Trials Logo

Non-vestibular Schwannoma clinical trials

View clinical trials related to Non-vestibular Schwannoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT04374305 Recruiting - Meningioma Clinical Trials

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

INTUITT-NF2
Start date: June 20, 2020
Phase: Phase 2
Study type: Interventional

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow people with multiple tumor types associated with NF2-SWN to receive new drugs throughout this study. Embedded within the Master Study are individual drug substudies. - Investigational Drug Sub-study A: Brigatinib - Investigational Drug Sub-study B: Neratinib